Scientific Programme Manager Medicines Repurposing

Closing date 15 August 2022
Location Netherlands or Remote
Hours 36-40 hours per week


We are looking for someone to support our strategy in drug repurposing (36-40 hours per week). The Scientific Programme Manager will be responsible for the implementation and execution of a sustainable Drug Repurposing Platform in Europe. This international initiative led by EATRIS – entitled REMEDI4ALL – will launch in September 2022 and comprise 24 partners in different functional domains from across Europe.

The REMEDI4ALL initiative will operate a complete, harmonised and accessible value chain integrating the scientific, methodological, financial, legal, regulatory, and intellectual property aspects of the repurposing approach. This will be conducted in a goal-oriented and patient-centric approach. Working closely together with research funders and the patient community, REMEDI4ALL will engage and support a substantial user base from both the non-profit and for-profit sectors.

Main responsibilities

  • Reporting to the Director of Medicines Development, and working with key technical and patient advocacy partners, you will support implementation and management of operations of the REMEDI4ALL consortium;
  • Manage a growing portfolio of drug repurposing projects. Ensure effective execution of multi-disciplinary non-clinical and clinical demonstrator projects to validate the DR platform and future proofing the DR process;
  • Liaise with technical and regulatory experts to generate DR development plans, ensure regulatory planning (e.g. IMPD);
  • Responsible for timely delivery of projects goals and milestones in collaboration with other project partners;
  • Responsible for defining and updating the catalogue of translational DR services to be offered by the DR platform and EATRIS member institutions;
  • Liaise with global and EU partners, about any project related operations, strategic direction and platform sustainability; bring expert opinion into policy debate.


  • Advanced degree in a biomedical science field (PhD);
  • Minimum 4 years of late-stage preclinical / early stage clinical medicines development experience, preferably in an industrial setting;
  • Experience in working with/leading multidisciplinary teams, familiar with the small molecule R&D value chain and EU regulatory aspects
  • Passionate about improving the medicinal products development ecosystem;
  • Familiarity with off- and on-patent repurposing is a plus;
  • Process oriented, strategic thinker with helicopter view and eye for identifying development bottlenecks;
  • Excellent writing and communication skills in English;
  • Experience in project management, preferably with experience in industry-partnered programmes.
  • Comfortable coordinating work across many research institutions, involving many external stakeholders and complex organisations;
  • Outstanding communicator and team player;
  • Self-motivated, service-oriented, flexible, yet able to prioritise and meet agreed deadlines;
  • A proactive approach to work, organised and able to travel when project requires.

What EATRIS offers

  • Fast-paced, multicultural environment where the coordination team, comprising 25 highly skilled colleagues from 8 countries, proud activists in translational medicine and accelerating impact for patients;
  • Competitive remuneration package;
  • A broad European network of biomedical researchers and innovation experts;
  • Opportunity to develop strategic and leadership skills;
  • A central office location that is within walking distance from Amsterdam Zuid station.

Application process

The position is based in Amsterdam, the Netherlands. Remote working arrangements for exceptional candidates will be considered. Only candidates with a valid work permit or who have the right to work in the Netherlands or in their country of residence will be considered.

Please send a copy of your CV and a letter of motivation (in English) by 15 August 2022 to Please note that a reference check is part of the selection process. For more information about the role, please email Martin de Kort (